Logo
Search

Rules:

Only words with 2 or more characters are accepted
Max 200 chars total
Space is used to split words, "" can be used to search for a whole string (not indexed search then)
AND, OR and NOT are prefix words, overruling the default operator
+/|/- equals AND, OR and NOT as operators.
All search words are converted to lowercase.

Search for "qtc"

Displaying results 1 to 9 out of 9

  Services 81%
  ... trials. The service panel of CRS in phase I-II human pharmacological trials includes BE/BA, FIM, POC, patient trials and specialties like QTc and renal/hepatic insufficiency. The in-house modular services Consultancy, Clinical Data Management (CDM), Statistical Analysis (STAT), ...
  Size: 30 K - Created: 18-11-12 - Modified: 28-06-17 16:13
Path: /Services

  Info-Point 78%
  ... any material without prior agreement by CRS. Scientific Publications / White Papers Poster Effect of Multiple Oral Doses of NOMAC/E2 on QTcF Intervals  News / Press Releases Press release Management Buy-Out at CRS Pressemitteilung Management Buy-Out bei der CRS News CRO Leadership ...
  Size: 39 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Info-Point

  In a Nutshell 75%
  ... and patients'. Please feel free to contact CRS directly. Special Fields of Expertise Interaction trials (food, drug & genotype) Thorough QT / QTc Renal & hepatic impairment Respiratory / inhalative devices Women's health / gynaecological examinations Men's health Dermal & transdermal ...
  Size: 31 K - Created: 12-08-15 - Modified: 13-07-17 15:29
Path: /CRS/In a Nutshell

  Mönchengladbach 73%
  ... performance of human pharmacology trials in all standard designs. CRS-Mönchengladbach is dedicated to implementing large-scale trials such as QTc (more than 150 subjects) and long-term trials (overnight stays up to 46 days) combined with challenging PK and PD schedules. In addition, the ...
  Size: 32 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Locations/Mönchengladbach

  Mannheim 69%
  ... of this unit include clinical pharmacology trials in all standard designs. This unit is dedicated to conducting large-scale trials such as QTc (more than 200 subjects) and long-term trials (overnight stays up to 56 days). Additionally, the unit has special expertise including ...
  Size: 33 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Locations/Mannheim

  2010-2017 67%
  ... of Nomegestrol Acetate (NOMAC)/17?-Estradiol (E2) on QTcF Intervals in Healthy Women: Results from a ... Estradiol and Estrone and their relationship on QTcF intervals in healthy women receiving multiple oral ... the effect of multiple oral doses of NOMAC/E2 on QTcF iIntervals in healthy women. Poster Figo 2012 Nave ... T , Peeters P. Sugammadex is not associated with QT/
  Size: 65 K - Created: 09-11-15 - Modified: 27-07-17 10:05
Path: /Expertise/Published Expertise/2010-2017

  Trial Expertise 65%
  ... therapy. Because genetic factors affect human responses to therapeutic drugs, CRS has access to a broad range of genotyped subjects . Thorough QTc/cardiac safety CRS has conducted 19 trials with cardiac safety monitoring and central ECG evaluation. Twelve of these studies have been TQT ...
  Size: 35 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Expertise/Trial Expertise

  2000 – 2009 51%
  ... Pharmacology (VkliPha 2008), November 6-8, 2008, Berlin. Timmer W. Cardiac Safety – Dr Wolfgang Timmer of CRS examines the conduct of thorough QTc trials in practice from a Phase I CRO's perspective. European Pharmaceutical Contractor 2008; (Summer 08). Timmer W. Minimising risk by ...
  Size: 53 K - Created: 09-11-15 - Modified: 20-06-17 17:09
Path: /Expertise/Published Expertise/2000 – 2009

  1990 – 1999 48%
  ... metrifonate in patients with renal impairment. Ther Drug Monit 1999 ; 21(3):310-316. Eckl KM, Thomsen T , Römer A, Dehn A. Terfenadine induced QTc-Prolongation in healthy subjects - a safety model. Eur J Clin Pharmacol 1999 ; 55 (No. 108). Rost KL, Fuhr U, Thomsen T , Zaigler M, ...
  Size: 61 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Expertise/Published Expertise/1990 – 1999

FooterEnd